Network meta-analysis on the efficacy and safety of finerenone versus SGLT2 inhibitors on reducing new-onset of atrial fibrillation in patients with type 2 diabetes mellitus and chronic kidney disease

被引：0
|
作者：
Yaofu Zhang
Junheng Wang
Li Jiang
Tongxin Wang
Zhuang Li
Xiaozhe Fu
Weijun Huang
Yonghua Xiao
Shidong Wang
Jinxi Zhao
机构：
[1] Beijing University of Chinese Medicine,Dongzhimen Hospital
[2] Xiyuan Hospital,National Clinical Research Center for Chinese Medicine Cardiology
[3] China Academy of Chinese Medical Sciences,undefined
[4] Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing,undefined
[5] Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine,undefined
来源：
Diabetology & Metabolic Syndrome | / 14卷
关键词：
Atrial fibrillation; SGLT2 inhibitors; Finerenone; Type 2 diabetes mellitus; Chronic kidney disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Network meta-analysis on the efficacy and safety of finerenone versus SGLT2 inhibitors on reducing new-onset of atrial fibrillation in patients with type 2 diabetes mellitus and chronic kidney disease
    Zhang, Yaofu
    Wang, Junheng
    Jiang, Li
    Wang, Tongxin
    Li, Zhuang
    Fu, Xiaozhe
    Huang, Weijun
    Xiao, Yonghua
    Wang, Shidong
    Zhao, Jinxi
    DIABETOLOGY & METABOLIC SYNDROME, 2022, 14 (01):
  • [2] Network Meta-Analysis on the Effects of SGLT2 Inhibitors Versus Finerenone on Cardiorenal Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease
    Zhao, Li-Min
    Zhan, Ze-Lin
    Ning, Jie
    Qiu, Mei
    FRONTIERS IN PHARMACOLOGY, 2022, 12
  • [3] Finerenone Reduces New-Onset Atrial Fibrillation in Patients With Chronic Kidney Disease and Type 2 Diabetes
    Filippatos, Gerasimos
    Bakris, George L.
    Pitt, Bertram
    Agarwal, Rajiv
    Rossing, Peter
    Ruilope, Luis M.
    Butler, Javed
    Lam, Carolyn S. P.
    Kolkhof, Peter
    Roberts, Luke
    Tasto, Christoph
    Joseph, Amer
    Anker, Stefan D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (02) : 142 - 152
  • [4] Systematic review and meta-analysis of the efficacy and safety of SGLT2 inhibitors in patients with type 2 diabetes mellitus
    Tsapas, A.
    Vassilakou, D.
    Athanasiadou, E.
    Karagiannis, T.
    Matthews, D. R.
    DIABETOLOGIA, 2012, 55 : S107 - S107
  • [5] Network meta-analysis on the effects of finerenone versus SGLT2 inhibitors and GLP-1 receptor agonists on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus and chronic kidney disease
    Zhang, Yaofu
    Jiang, Li
    Wang, Junheng
    Wang, Tongxin
    Chien, Chieh
    Huang, Weijun
    Fu, Xiaozhe
    Xiao, Yonghua
    Fu, Qiang
    Wang, Shidong
    Zhao, Jinxi
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [6] Network meta-analysis on the effects of finerenone versus SGLT2 inhibitors and GLP-1 receptor agonists on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus and chronic kidney disease
    Yaofu Zhang
    Li Jiang
    Junheng Wang
    Tongxin Wang
    Chieh Chien
    Weijun Huang
    Xiaozhe Fu
    Yonghua Xiao
    Qiang Fu
    Shidong Wang
    Jinxi Zhao
    Cardiovascular Diabetology, 21
  • [7] Efficacy and safety profile of SGLT2 inhibitors in patients with type 2 diabetes and chronic kidney disease
    Scheen, Andre J.
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (03) : 243 - 256
  • [8] Cardiorenal Effects of Sglt2 Inhibitors and Finerenone in Type 2 Diabetes and Chronic Kidney Disease. Single, Dual or Triple Therapy? A Network Meta-Analysis
    Acevedo, Jesus Diaz
    Lazcano, Greilys
    Soto, Mariana
    Castro, Adela
    Penaherrera, Carlos
    Buitrago, Andres F.
    Narayanankutty, Naveen Punchayil
    Navas, Viviana
    Pino, Jesus E.
    CIRCULATION, 2022, 146
  • [9] EFFECTIVENESS OF SGLT2 INHIBITORS IN REDUCING ATRIAL FIBRILLATION RECURRENCE RISK FOLLOWING CATHETER ABLATION IN TYPE 2 DIABETES MELLITUS: A META-ANALYSIS
    Soliman, Youssef
    Abuelazm, Mohamed
    Ellabban, Mohamed
    Mouffokes, Adel
    Abdelazeem, Basel
    Saeed, Shahzeb
    Hassaballa, Hatem
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 6 - 6
  • [10] Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta-analysis
    Toyama, Tadashi
    Neuen, Brendon L.
    Jun, Min
    Ohkuma, Toshiaki
    Neal, Bruce
    Jardine, Meg J.
    Heerspink, Hiddo L.
    Wong, Muh Geot
    Ninomiya, Toshiharu
    Wada, Takashi
    Perkovic, Vlado
    DIABETES OBESITY & METABOLISM, 2019, 21 (05): : 1237 - 1250
12345